Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Cefiderocol sulfate tosylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefiderocol sulfate tosylate, including repackagers and relabelers. The FDA regulates Cefiderocol sulfate tosylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefiderocol sulfate tosylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cefiderocol sulfate tosylate supplier is an individual or a company that provides Cefiderocol sulfate tosylate active pharmaceutical ingredient (API) or Cefiderocol sulfate tosylate finished formulations upon request. The Cefiderocol sulfate tosylate suppliers may include Cefiderocol sulfate tosylate API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cefiderocol sulfate tosylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cefiderocol sulfate tosylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cefiderocol sulfate tosylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cefiderocol sulfate tosylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cefiderocol sulfate tosylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cefiderocol sulfate tosylate suppliers with NDC on PharmaCompass.
Cefiderocol sulfate tosylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefiderocol sulfate tosylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefiderocol sulfate tosylate GMP manufacturer or Cefiderocol sulfate tosylate GMP API supplier for your needs.
A Cefiderocol sulfate tosylate CoA (Certificate of Analysis) is a formal document that attests to Cefiderocol sulfate tosylate's compliance with Cefiderocol sulfate tosylate specifications and serves as a tool for batch-level quality control.
Cefiderocol sulfate tosylate CoA mostly includes findings from lab analyses of a specific batch. For each Cefiderocol sulfate tosylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefiderocol sulfate tosylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefiderocol sulfate tosylate EP), Cefiderocol sulfate tosylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefiderocol sulfate tosylate USP).
LOOKING FOR A SUPPLIER?
